Literature DB >> 19623635

The expression of vascular endothelial growth factor in skeletal muscle of patients with sleep disorders.

Britta Wåhlin-Larsson1, Jan Ulfberg, Karin Piehl Aulin, Fawzi Kadi.   

Abstract

An increased capillary network has been observed in skeletal muscle of patients with restless legs syndrome (RLS) and obstructive sleep apnea syndrome (OSAS). This finding could be due to upregulation of growth factors responsible for angiogenesis. The aim of the study was to examine the occurrence and localization of VEGF and capillary proliferation in skeletal muscle of RLS (n = 12) and OSAS (n = 12) patients and controls (n = 11). Double-immunofluorescence staining for capillaries (CD31) and VEGF, and proliferating cells (Ki-67), was carried out on biopsies taken from the tibialis anterior. The percentage of capillaries expressing VEGF (CD31,VEGF(+)) was significantly higher in OSAS and RLS patients compared with controls. The percentage of proliferating capillaries (CD31,Ki-67(+)) was significantly higher in OSAS patients compared with controls. Our study shows the occurrence of proliferation of endothelial cells in skeletal muscle in RLS and OSAS, supporting an upregulation of VEGF located in capillaries, probably due to local hypoxia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19623635     DOI: 10.1002/mus.21357

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  16 in total

1.  Impaired endothelial function may predict treatment response in restless legs syndrome.

Authors:  Min Seung Kim; Dong Gyu Park; Jung Han Yoon
Journal:  J Neural Transm (Vienna)       Date:  2019-06-19       Impact factor: 3.575

Review 2.  Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier.

Authors:  Diane C Lim; Allan I Pack
Journal:  Sleep Med Rev       Date:  2013-03-28       Impact factor: 11.609

3.  Decreased Symptoms without Augmented Skin Blood Flow in Subjects with RLS/WED after Vibration Treatment.

Authors:  Ulrike H Mitchell; Sterling C Hilton; Erik Hunsaker; Jan Ulfberg
Journal:  J Clin Sleep Med       Date:  2016-07-15       Impact factor: 4.062

4.  Incidence of restless legs syndrome and its correlates.

Authors:  Pooja Budhiraja; Rohit Budhiraja; James L Goodwin; Richard P Allen; Anne B Newman; Brian B Koo; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2012-04-15       Impact factor: 4.062

5.  Iron and restless legs syndrome: treatment, genetics and pathophysiology.

Authors:  James R Connor; Stephanie M Patton; Konrad Oexle; Richard P Allen
Journal:  Sleep Med       Date:  2016-11-10       Impact factor: 3.492

6.  Pramipexole alters thermoregulation in restless legs syndrome.

Authors:  Aaro V Salminen; Ville Rimpilä; Olli Polo
Journal:  J Clin Sleep Med       Date:  2014-12-15       Impact factor: 4.062

Review 7.  Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology.

Authors:  Richard P Allen
Journal:  Sleep Med Clin       Date:  2015-07-15

8.  Different cyclical intermittent hypoxia severities have different effects on hippocampal microvasculature.

Authors:  Diane C Lim; Daniel C Brady; Rajath Soans; Emily Y Kim; Laise Valverde; Brendan T Keenan; Xiaofeng Guo; Woo Young Kim; Min Jeong Park; Raymond Galante; James A Shackleford; Allan I Pack
Journal:  J Appl Physiol (1985)       Date:  2016-04-28

9.  Evaluation of Cardiovascular Risk Factors and Restless Legs Syndrome in Women and Men: A Preliminary Population-Based Study in China.

Authors:  Yuqiong Liu; Gangqiong Liu; Ling Li; Jing Yang; Shengli Ma
Journal:  J Clin Sleep Med       Date:  2018-03-15       Impact factor: 4.062

Review 10.  Medical devices for restless legs syndrome - clinical utility of the Relaxis pad.

Authors:  Ulrike H Mitchell
Journal:  Ther Clin Risk Manag       Date:  2015-12-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.